Susan Choe, DO
Family Medicine · Circleville, OHNPI 1891157426
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 24.2% of the total. Reporting peaked in 2023 at $1,013 and has fallen 66.8% since, to $337 in 2024.
Across 153 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$580
- Novo Nordisk$189
- Lilly USA, LLC$151
- Pfizer$138
- Merck$117
- Exact Sciences$114
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,401100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $580 |
| Novo Nordisk | 13 | $189 |
| Lilly USA, LLC | 10 | $151 |
| Pfizer | 8 | $138 |
| Merck | 8 | $117 |
| Exact Sciences | 5 | $114 |
| Dexcom, Inc. | 6 | $110 |
| Abbott | 6 | $106 |
| Bayer | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $101 |
| Amgen | 4 | $72 |
| Astellas Pharma US Inc | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| GSK | 4 | $56 |
| Novartis | 3 | $52 |
| Amarin Pharma, Inc. | 3 | $43 |
| AstraZeneca | 3 | $40 |
| Sanofi Pasteur Inc. | 1 | $33 |
| Esperion Therapeutics, Inc. | 1 | $27 |
| Johnson & Johnson | 2 | $23 |
| Medtronic | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Lucid Diagnostics Inc. | 1 | $20 |
| Insulet Corporation | 1 | $18 |
| Cranial Technologies, Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Alfasigma USA, Inc. | 1 | $11 |
| Boehringer Ingelheim | 1 | $11 |
How this compares
$2,401 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 69 | $569 |
| Rosuvastatin Calcium | 16 | $442 |
| Levothyroxine Sodium | 29 | $370 |
| Omeprazole | 25 | $314 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $268 |
| Amitriptyline Hcl | 11 | $138 |
| Losartan Potassium | 12 | $133 |
| Pravastatin Sodium | 11 | $130 |
| Fluticasone Propionate | 13 | $123 |
| Metoprolol Succinate | 11 | $111 |
| Lisinopril | 20 | $110 |
| Sertraline Hcl | 12 | $84 |
| Trazodone Hcl | 11 | $71 |
| Hydrochlorothiazide | 12 | $55 |
| Famotidine | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Circleville
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.